Search results
Results from the WOW.Com Content Network
The U.S. Kefauver–Harris Amendment or "Drug Efficacy Amendment" is a 1962 amendment to the Federal Food, Drug, and Cosmetic Act. It introduced a requirement for drug manufacturers to provide proof of the effectiveness and safety of their drugs before approval, [1] [2] required drug advertising to disclose accurate information about side effects, and stopped cheap generic drugs being marketed ...
The Pharmacy Competition and Consumer Choice Act of 2011 (H.R. 1971) is the legislation that was introduced in the 112th United States Congress on May 24, 2011, with the full title of the bill stating to "amend the Public Health Service Act to ensure transparency and proper operation of pharmacy benefit managers". [1]
The Multistate Pharmacy Jurisprudence Examination (MPJE) is a pharmacy law examination created by the National Association of Boards of Pharmacy (NABP) in the United States to help individual state boards of pharmacy assess the competency and knowledge of pharmacy law. [1]
Pharmacy Benefit Managers reform, including delinking PBM profits from high drug prices, enjoys broad bipartisan support. Congress can lower drug prices with new laws to reform Pharmacy Benefits ...
The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices.
In the United States, regulation of drugs was originally a state right, as opposed to federal right. But with the increase in fraudulent practices due to private incentives to maximize profits and poor enforcement of state laws, the need for stronger federal regulation increased. [7]
ASPL is a nonprofit organization with the purposes of furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues; communicating accurate legal educational information; and providing educational ...
Pharmaceutical policy is a branch of health policy that deals with the development, provision and use of medications within a health care system.It embraces drugs (both brand name and generic), biologics (products derived from living sources, as opposed to chemical compositions), vaccines and natural health products.